美国食品和药物管理局批准辉瑞-生物科技公司的 COVID-19 疫苗后，COVID-19 疫苗的接种和接种意愿。
COVID-19 Vaccine Uptake and Intentions Following US Food and Drug Administration Approval of the Pfizer-BioNTech COVID-19 Vaccine.
机构信息
Department of Internal Medicine, University of Iowa, Iowa City.
RAND Corporation, Pittsburgh, Pennsylvania.
出版信息
JAMA Intern Med. 2022 Jun 1;182(6):678-680. doi: 10.1001/jamainternmed.2022.0761.
Abstract
This survey study assesses vaccination intentions of unvaccinated US adults in response to full US Food and Drug Administration (FDA) approval of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine and any demographic characteristics associated with those intentions.
摘要
这项调查研究评估了未接种疫苗的美国成年人对美国食品和药物管理局（FDA）全面批准 BNT162b2（辉瑞-生物科技）COVID-19 疫苗的反应以及与这些意图相关的任何人口统计学特征的接种意愿。
相似文献
1
COVID-19 Vaccine Uptake and Intentions Following US Food and Drug Administration Approval of the Pfizer-BioNTech COVID-19 Vaccine.美国食品和药物管理局批准辉瑞-生物科技公司的 COVID-19 疫苗后，COVID-19 疫苗的接种和接种意愿。
JAMA Intern Med. 2022 Jun 1;182(6):678-680. doi: 10.1001/jamainternmed.2022.0761.
2
COVID-19 Updates: Pfizer-BioNTech COVID-19 vaccine.新冠疫情最新消息：辉瑞-生物科技公司新冠疫苗
Med Lett Drugs Ther. 2022 Jan 24;64(1642):16.
3
Finally, an FDA Approval for an Immunization Against COVID-19: Hope on the Horizon.终于，COVID-19 疫苗获得 FDA 批准：曙光在望。
Ann Pharmacother. 2022 Sep;56(9):1058-1064. doi: 10.1177/10600280211058387. Epub 2022 Jan 10.
4
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.免疫实践咨询委员会关于在 5-11 岁儿童中使用辉瑞-生物技术公司 COVID-19 疫苗的临时建议-美国，2021 年 11 月。
MMWR Morb Mortal Wkly Rep. 2021 Nov 12;70(45):1579-1583. doi: 10.15585/mmwr.mm7045e1.
5
Vaccine Uptake in the US After Full Food and Drug Administration Approval of the BNT162b2 mRNA COVID-19 Vaccine.美国食品药品监督管理局全面批准BNT162b2 mRNA新冠疫苗后的疫苗接种情况
JAMA Netw Open. 2022 Apr 1;5(4):e226108. doi: 10.1001/jamanetworkopen.2022.6108.
6
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.美国 2022 年 6 月关于在 6 个月至 5 岁儿童中使用 Moderna 和辉瑞-BioNTech COVID-19 疫苗的免疫实践咨询委员会临时建议。
MMWR Morb Mortal Wkly Rep. 2022 Jul 1;71(26):859-868. doi: 10.15585/mmwr.mm7126e2.
7
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.2021年3月至8月美国Moderna、辉瑞-生物科技公司和杨森（强生）疫苗在预防无免疫功能低下状况成年人新冠病毒肺炎住院方面的比较效果
MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1337-1343. doi: 10.15585/mmwr.mm7038e1.
8
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.《16 岁及以上人群使用辉瑞-生物科技公司的 COVID-19 疫苗：免疫实践咨询委员会的建议——美国，2021 年 9 月》。
MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1344-1348. doi: 10.15585/mmwr.mm7038e2.
9
Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States.辉瑞-生物科技 COVID-19 疫苗（BNT162b2）在美国推出第一年的公共卫生影响。
J Med Econ. 2022 Jan-Dec;25(1):605-617. doi: 10.1080/13696998.2022.2071427.
10
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021.免疫实践咨询委员会关于辉瑞-BioNTech COVID-19 疫苗在 12-15 岁青少年中使用的临时建议-美国，2021 年 5 月。
MMWR Morb Mortal Wkly Rep. 2021 May 21;70(20):749-752. doi: 10.15585/mmwr.mm7020e1.
引用本文的文献
1
The effect of a pilot brief educational intervention on preferences regarding treatments for opioid use disorder.一项试点简短教育干预对阿片类物质使用障碍治疗偏好的影响。
Drug Alcohol Depend Rep. 2024 Apr 24;11:100235. doi: 10.1016/j.dadr.2024.100235. eCollection 2024 Jun.
2
Development of COVID-19 vaccine policy - United States, 2020-2023.COVID-19 疫苗政策的制定 - 美国，2020-2023 年。
Vaccine. 2024 Sep 17;42 Suppl 3(Suppl 3):125512. doi: 10.1016/j.vaccine.2023.12.022. Epub 2023 Dec 29.
3
Understanding the impact of rapid antigen tests on SARS-CoV-2 transmission in the fifth wave of COVID-19 in Hong Kong in early 2022.理解 2022 年初香港第五波 COVID-19 中快速抗原检测对 SARS-CoV-2 传播的影响。
Emerg Microbes Infect. 2022 Dec;11(1):1394-1401. doi: 10.1080/22221751.2022.2076616.
Zotero 插件